Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Regulation of interferon-dependent mRNA translation of target genes.

Kroczynska B, Mehrotra S, Arslan AD, Kaur S, Platanias LC.

J Interferon Cytokine Res. 2014 Apr;34(4):289-96. doi: 10.1089/jir.2013.0148. Epub 2014 Feb 21. Review.

2.

Mechanisms of type I interferon signaling in normal and malignant cells.

Li Y, Srivastava KK, Platanias LC.

Arch Immunol Ther Exp (Warsz). 2004 May-Jun;52(3):156-63. Review.

PMID:
15247882
3.

Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling.

Kaur S, Lal L, Sassano A, Majchrzak-Kita B, Srikanth M, Baker DP, Petroulakis E, Hay N, Sonenberg N, Fish EN, Platanias LC.

J Biol Chem. 2007 Jan 19;282(3):1757-68. Epub 2006 Nov 17.

4.

Growth suppressive cytokines and the AKT/mTOR pathway.

Kroczynska B, Kaur S, Platanias LC.

Cytokine. 2009 Oct-Nov;48(1-2):138-43. doi: 10.1016/j.cyto.2009.07.009. Epub 2009 Aug 13. Review.

PMID:
19682919
5.

Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.

Lekmine F, Uddin S, Sassano A, Parmar S, Brachmann SM, Majchrzak B, Sonenberg N, Hay N, Fish EN, Platanias LC.

J Biol Chem. 2003 Jul 25;278(30):27772-80. Epub 2003 May 20.

6.
7.

Role of the Akt pathway in mRNA translation of interferon-stimulated genes.

Kaur S, Sassano A, Dolniak B, Joshi S, Majchrzak-Kita B, Baker DP, Hay N, Fish EN, Platanias LC.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4808-13. doi: 10.1073/pnas.0710907105. Epub 2008 Mar 13.

8.

Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis.

Tanaka MH, Giro EM, Cavalcante LB, Pires JR, Apponi LH, Valentini SR, Spolidório DM, Capela MV, Rossa C Jr, Scarel-Caminaga RM.

Cytokine. 2012 Dec;60(3):875-81. doi: 10.1016/j.cyto.2012.08.020. Epub 2012 Sep 18.

9.

Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells.

Parmar S, Smith J, Sassano A, Uddin S, Katsoulidis E, Majchrzak B, Kambhampati S, Eklund EA, Tallman MS, Fish EN, Platanias LC.

Blood. 2005 Oct 1;106(7):2436-43. Epub 2005 Mar 24.

10.

Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains.

Takaoka A, Mitani Y, Suemori H, Sato M, Yokochi T, Noguchi S, Tanaka N, Taniguchi T.

Science. 2000 Jun 30;288(5475):2357-60.

11.

Multifaceted activities of type I interferon are revealed by a receptor antagonist.

Levin D, Schneider WM, Hoffmann HH, Yarden G, Busetto AG, Manor O, Sharma N, Rice CM, Schreiber G.

Sci Signal. 2014 May 27;7(327):ra50. doi: 10.1126/scisignal.2004998.

12.

Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins.

David M, Petricoin E 3rd, Benjamin C, Pine R, Weber MJ, Larner AC.

Science. 1995 Sep 22;269(5231):1721-3.

PMID:
7569900
13.

Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses.

Kroczynska B, Sharma B, Eklund EA, Fish EN, Platanias LC.

Mol Cell Biol. 2012 Jul;32(14):2809-22. doi: 10.1128/MCB.00310-12. Epub 2012 May 14. Erratum in: Mol Cell Biol. 2012 Sep;32(17):3608.

14.

Interferon targeted genes in host defense.

Kunzi MS, Pitha PM.

Autoimmunity. 2003 Dec;36(8):457-61. Review.

PMID:
14984022
15.

Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.

Zaritsky LA, Bedsaul JR, Zoon KC.

J Virol. 2015 Nov;89(22):11534-48. doi: 10.1128/JVI.01727-15. Epub 2015 Sep 9.

16.

Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.

Eid P, Langer JA, Bailly G, Lejealle R, Guymarho J, Tovey MG.

Eur Cytokine Netw. 2000 Dec;11(4):560-73.

PMID:
11125298
17.

Regulation of mRNA translation by signaling pathways.

Roux PP, Topisirovic I.

Cold Spring Harb Perspect Biol. 2012 Nov 1;4(11). pii: a012252. doi: 10.1101/cshperspect.a012252. Review.

19.

Mechanisms of type III interferon expression.

Iversen MB, Paludan SR.

J Interferon Cytokine Res. 2010 Aug;30(8):573-8. doi: 10.1089/jir.2010.0063. Review.

PMID:
20645874
20.

Functional role of type I and type II interferons in antiviral defense.

Müller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M.

Science. 1994 Jun 24;264(5167):1918-21.

PMID:
8009221
Items per page

Supplemental Content

Write to the Help Desk